THERMO FISHER SCIENTIFIC INC.
Government Contracts & Awards
ADVANCED TECHNOLOGY INTERNATIONAL: $19.6M Department of Health and Human Services Contract
$19,620,884ADVANCED TECHNOLOGY INTERNATIONAL: $304M Department of Health and Human Services Contract
$303,999,997Proprietary Tech & Patents
METHOD FOR QUANTITATIVE MONITORING MRNA CAPPING EFFICIENCY
Form D Funding
No recent SEC Form D filings found.
Market Intelligence & News
Top Technology Executives Recognized at the 2026 Carolina CIO ORBIE Awards
Leading CIOs honored for leadership, innovation, and business impact at the Carolina CIO ORBIE Awards on September 10, 2026, at The Westin Charlotte. CHARLOTTE, N.C., Sept. 14, 2026 (GLOBE NEWSWIRE) -- The 2026 Carolina CIO ORBIE Awards honored leading chief information officers (CIOs) from MetLife, Thermo Fisher Scientific, Armstrong Transport Group, Duke Energy, Beacon Mobility, Rodgers Builders, Hornets Sports & Entertainment, and North Carolina Rate Burreau for their exceptional leadership.
Stronger Q2 Results And New Supply Deal Might Change The Case For Investing In LivaNova (LIVN)
LivaNova PLC recently reported second-quarter 2026 results showing sales rising to US$390.59 million and net income climbing to US$108.57 million, alongside higher earnings per share versus a year earlier. On the back of this performance, the company raised its 2026 constant-currency revenue growth guidance to a range of 8% to 9% and secured a long-term oxygenator supply agreement with Thermo Fisher Scientific to support manufacturing expansion. Now we’ll examine how the raised 2026 growth...
LivaNova (LIVN) Could Be 5% Undervalued Following Raised 2026 Guidance
LivaNova (LIVN) raised its full year 2026 revenue and earnings guidance after reporting record quarterly revenue and significantly higher profitability, supported by demand for its Essenz heart-lung machine and a new supply agreement with Thermo Fisher Scientific. See our latest analysis for LivaNova. LivaNova's recent guidance lift comes after a strong run in the share price, with a 90 day share price return of 12.71% and a year to date share price return of 33.21%. The 1 year total...
Astorg Completes Acquisition of Microbiology Business From Thermo Fisher Scientific, Establishing an Independent Global Diagnostics Specialist
LUXEMBOURG & NEW YORK & PARIS, August 12, 2026--Astorg, a leading pan-European private equity firm, today announced the successful completion of its acquisition of the global microbiology business from Thermo Fisher Scientific. The business will now operate as an independent company under the leadership of Chief Executive Officer Dirk Bontridder and will launch under a new corporate brand later in 2026.
Thermo Fisher Scientific Completes Sale of its Microbiology Business to Astorg
WALTHAM, Mass., August 12, 2026--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has completed the sale of its microbiology business to Astorg, a leading pan-European private equity firm, for consideration of approximately $1.075 billion, consisting of cash and a $50 million seller note.
Following Hamamatsu's Rebranding of NKT Photonics to Drive Laser Innovation, New Biophotonics Market Overview Maps Strategic Growth Through 2030
Accelerating momentum across major industry heavyweights—highlighted by Thermo Fisher Scientific’s Q2 2026 revenue beat, Hamamatsu Photonics’ launch of its dedicated Lasers & Fibers Business Unit, and BD’s $4.98 billion Q3 performance—is driving rapid adoption of optical diagnostic and imaging solutions worldwide. This report provides an in-depth analysis of key technological advancements, regional market shares, and competitive strategies across the global biophotonics sector. Biophotonics Mark
Can A New Vitiligo Registry Move The Needle For Thermo Fisher (TMO)?
Thermo Fisher Scientific (NYSE:TMO) mostly sells the instruments and supplies that let other companies do science, not the treatments themselves. So when the company said on July 29 that it had launched the PPD CorEvitas Vitiligo Registry on July 14, to track how patients with nonsegmental vitiligo respond to treatment, it pointed to a quieter […]
$1000 Invested In Thermo Fisher Scientific 10 Years Ago Would Be Worth This Much Today
Thermo Fisher Scientific (NYSE:TMO) has outperformed the market over the past 10 years by 1.15% on an annualized basis producing an average annual return of 14.61%. Currently, Thermo Fisher Scientific has a market
Thermo Fisher Scientific Collaborates with The Michael J. Fox Foundation to Advance Proteomics-Enabled Parkinson’s Precision Medicine
WALTHAM, Mass., August 11, 2026--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the completion of Olink Explore HT proteomic analysis of approximately 5,500 research samples from The Michael J. Fox Foundation’s (MJFF) landmark study, the Parkinson’s Precision Medicine Initiative (PPMI). The resulting data are now in PPMI’s data repository, where they are available to the global research community.
Thermo Fisher (TMO) vs Danaher (DHR): Which Life Sciences Stock Looks Better Positioned?
Thermo Fisher Scientific Inc. (NYSE:TMO) and Danaher Corporation (NYSE:DHR) are two of the world’s largest life sciences tools companies, making them natural competitors for investors looking to capitalize on a recovery in pharmaceutical and biotechnology research spending. Both companies delivered better-than-expected second-quarter results, but while Thermo Fisher (NYSE:TMO) raised guidance on broad-based demand improvement, Danaher’s […]
Congressional Trades in $TMO
Insider Trades (Form 4)
Britt Lisa P.
CASPER MARC N
CASPER MARC N
Key People
Britt Lisa P
Sr. VP and Chief HR Officer
CASPER MARC N
Chairman & CEO
CASPER MARC N
Chairman & CEO
Political Giving
$155,000 given to 29 candidates across 75 disclosed contributions (FEC Schedule A).
Scott H. Peters
Blake Moore
Katherine M. Clark
Thomas H. Kean
Deborah Ross
Robert J. Wittman
Joseph D. Morelle
Susan M. Collins
Shelley Moore Capito
Andrew Garbarino
James French Hill
John Curtis
Adrian Smith
Jake Auchincloss
Charles J. "Chuck" Fleischmann
Darin McKay LaHood
Thom Tillis
Adam Smith
Suzan K. DelBene
Lori Trahan
+ 9 more recipients not shown.
Factual Connections
Connections to other companies, executives, and politicians — sourced from disclosed trades, shared officers/directors, and public filings — are a Pro/Alpha feature.
Upgrade to Pro